Audax Private Equity Rebrands Avantor, Inc.'s Services Arm
Audax Private Equity Completes Acquisition of Avantor’s Clinical Services
Audax Private Equity has successfully finished its acquisition of the clinical services sector from Avantor, Inc. (NYSE: AVTR). The company now operates under a new name, Resonant Clinical Solutions. This rebranding reflects the company's commitment to collaboration with its dedicated employees and clients. Resonant aims to deliver exceptional services in the clinical trial domain.
The Strength of Resonant Clinical Solutions
Resonant Clinical Solutions incorporates three respected brands: EPL Archives, MESM, and Therapak. With a legacy dating back to the 1970s, these brands collectively provide a wide-ranging and quality-focused suite of services designed for pharmaceutical and biotechnology companies, as well as contract research organizations (CROs) and diagnostic laboratories.
Investments and Future Growth
Under the stewardship of Audax, Resonant is set to benefit from significant investments aimed at enhancing its operational capabilities. The goal is to accelerate organic growth alongside strategic acquisitions. Audax has plans designed to promote a smooth transition for Resonant into this new chapter of its journey.
Expert Insights on Market Demand
David Wong, a Partner at Audax Private Equity, shared insights regarding the market dynamics shaping the clinical services landscape. He emphasized that the growing intricacies involved in clinical trials have prompted pharmaceutical sponsors and CROs to utilize specialized services. Resonant’s comprehensive offerings will enable clients to navigate these complexities effectively, thereby allowing them to concentrate on critical drug discovery and research and development (R&D) tasks.
Commitment to Client Relationships
Stephen Weaver, Managing Director at Audax, noted the value that Resonant’s longstanding client relationships will bring to its growth trajectory. He believes that this foundation will be pivotal as the company continues on its path as an independent entity in the outsourced clinical trial services market.
Advisors in the Transition
As part of the acquisition, various firms provided essential advisory services. Moelis & Company LLC acted as the financial advisor to Audax, and Ropes & Gray LLP offered legal counsel. On the other side, J.P. Morgan Securities LLC was the exclusive financial advisor for Avantor, while Arnold & Porter served as Avantor’s legal advisor.
About Audax Private Equity
Audax Private Equity, headquartered in Boston, operates with a diverse portfolio across various strategies. These strategies include Flagship and Origins, which focus on control buyouts in both middle and lower-middle markets, alongside a Strategic Capital strategy providing tailored equity solutions for growth. With around $19 billion in managed assets, Audax has cultivated a robust track record since its inception in 1999, with an emphasis on fostering company growth and optimizing operations.
About Resonant Clinical Solutions
Resonant Clinical Solutions represents a major player in the clinical trial and laboratory supply chain services arena, employing over 850 staff members. The company has established itself as a trusted partner within the pharmaceutical industry, offering critical support through its ten strategically located facilities across several countries in Europe, as well as the US and UK. Their global logistics and equipment services network further enhances their capability to address the complexities of supply chain management that their clients face.
Frequently Asked Questions
What is the new name of Avantor’s clinical services business?
The clinical services business of Avantor has been rebranded as Resonant Clinical Solutions.
Who acquired Avantor’s clinical services business?
Audax Private Equity completed the acquisition of Avantor’s clinical services business.
What are the main services offered by Resonant Clinical Solutions?
Resonant Clinical Solutions provides clinical trial services and laboratory supply chain services to pharmaceutical and biotech companies, CROs, and diagnostic labs.
Where does Resonant operate?
Resonant operates facilities in the US, UK, and Europe, complemented by a global logistics network.
What is Audax's approach to portfolio management?
Audax focuses on a Buy & Build approach, aiming to enhance revenue and optimize operations within their portfolio companies.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- ChoiceOne Financial Services Achieves Record Growth and Stability
- Significant Capital Influx into U.S. Equity Funds: Insights
- Protego Biopharma Stock Soars to New Heights Amid Growth
- Bridgemarq Real Estate Services Enhances Shareholder Value
- Katahdin Enhances Environmental Services with SGS Partnership
- Abich Financial Services Unveils New Office with Celebration
- MolinaCares Accord Boosts Health Equity in Iowa with Grant
- Transform Your Outdoors with Knockout Mosquito & Tick Services
- E-Home Household Services Launches Resource Recycling Initiative
- Supernus Pharmaceuticals Shows Promising Developments in MDD Trials
Recent Articles
- SOBR Safe, Inc. Sees Unprecedented Surge in Stock Prices
- Kaspi.kz Reports Strong Financial Performance in 2024
- CVS Health's Leadership Change Amid Financial Reassessments
- Ally Financial's Impressive Earnings Performance in Q3 2024
- Transformative Impact of 5G and AI Highlighted at GITEX Global
- Kroll Liquidators Achieve Major Settlement with FTX Estate
- Frontera Energy Corporation Shares Buyback Results Announced
- Pan Global Secures $7 Million Financing for Future Exploration
- Valour Inc. Enhances Nordic Market Strategy with ETP Transfer
- Endo, Inc. Showcases Advancements in Plantar Fibromatosis Treatment
- UScellular's Strategic Spectrum Sale Enhances Network Value
- Tobacco Giants Face Major Settlement for Legal Dispute
- SP Group A/S Launches Exciting Share Buy-Back Initiative
- Novartis Seeks Approval for Kisqali in Early Breast Cancer Treatment
- Understanding the Importance of Broker Awards in Trading
- MESCIUS Inc. Triumphs at the 2024 Visual Studio Magazine Awards
- Kroll Facilitates Major Settlement Between Emergent and FTX
- Exploring the Future of Data Centers at GITEX GLOBAL 2024
- Join the Fun: Natural Grocers' Family-Friendly Spooktacular Event
- SentinelOne Maintains Strong Market Position with Growth Potential
- Consumers Energy Secures $20 Million for Smart Grid Technology
- Goldman Sachs Upholds Sell Rating for Manpower Inc. Amid Concerns
- Rexford Industrial Realty's Outlook: Growth Amid Challenges
- Jefferies Adjusts Clearway Energy's Price Target Amid Changes
- Canaccord Reduces Okta Price Target but Keeps Hold Rating
- American Express Surpasses Earnings Expectations Amid Growth
- American Express Surpasses Earnings Expectations Yet Revenue Misses
- Procter & Gamble Reports Lower Than Expected Quarterly Sales
- Fifth Third Bancorp's Q3 Earnings Report and Stock Movement Insights
- Regions Financial's Q3 Earnings Show Disparity with Revenue
- Procter & Gamble Surpasses Analyst Expectations Despite Revenue Dip
- Investing in Dividend Stocks: Risks and Insights
- Understanding Social Security's Impact on Retirement Plans
- Laser Photonics Expands Partnership with Acuren Through Sales
- Karen C. Francis Honored in 2024 NACD Directorship 100
- CDW Corporation Set to Share Quarterly Insights Soon
- Innovative Industrial Properties Announces Q4 Earnings Call Details
- Actineer Joint Venture Advances Production of Actinium-225
- Allegion Enhances Security Offerings with SOSS Acquisition
- Netcompany Navigates Strategic Share Buyback Program
- TotalEnergies Boosts Brazilian Market by Selling Fuel Division
- CI Financial Achieves Record Total Assets in Wealth Management
- American Express Achieves Record Q3 Earnings and Outlook Boost
- First Financial Bankshares Projects Positive Growth Ahead
- Intuitive Surgical: Strong Financial Performance and Outlook
- Netflix's Growth Prospects and Market Adaptations Ahead
- Stifel Downgrades SUSS MicroTec to Hold Amid Lowered Outlook
- Oppenheimer Holds Perform Rating for Intuitive Surgical Amid Growth
- Investors Eye Strong Returns from China ETFs Amid Growth Data
- Positive Growth for Blackstone Amid Market Observations